These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24935984)

  • 21. Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ
    Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
    Rich KA; Fox A; Yalvac M; Heintzman S; Tellez M; Bartlett A; Severyn S; Linsenmayer M; Kelly K; Reynolds J; Sterling GB; Weaver T; Rajneesh K; Pino MG; Arnold WD; Elsheikh B; Kolb SJ
    J Neuromuscul Dis; 2022; 9(1):111-119. PubMed ID: 34776417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury.
    Tigchelaar S; Gupta R; Shannon CP; Streijger F; Sinha S; Flibotte S; Rizzuto MA; Street J; Paquette S; Ailon T; Charest-Morin R; Dea N; Fisher C; Dvorak MF; Dhall S; Mac-Thiong JM; Parent S; Bailey C; Christie S; Van Keuren-Jensen K; Nislow C; Kwon BK
    J Neurotrauma; 2019 Aug; 36(15):2358-2371. PubMed ID: 30827169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.
    Moseby-Knappe M; Mattsson N; Nielsen N; Zetterberg H; Blennow K; Dankiewicz J; Dragancea I; Friberg H; Lilja G; Insel PS; Rylander C; Westhall E; Kjaergaard J; Wise MP; Hassager C; Kuiper MA; Stammet P; Wanscher MCJ; Wetterslev J; Erlinge D; Horn J; Pellis T; Cronberg T
    JAMA Neurol; 2019 Jan; 76(1):64-71. PubMed ID: 30383090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the acute magnetic resonance imaging features reflect neurologic prognosis in patients with cervical spinal cord injury?
    Matsushita A; Maeda T; Mori E; Yuge I; Kawano O; Ueta T; Shiba K
    Spine J; 2017 Sep; 17(9):1319-1324. PubMed ID: 28501580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neurofilament light chain as a prognostic marker in postanoxic encephalopathy.
    Disanto G; Prosperetti C; Gobbi C; Barro C; Michalak Z; Cassina T; Kuhle J; Casso G; Agazzi P
    Epilepsy Behav; 2019 Dec; 101(Pt B):106432. PubMed ID: 31375414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis.
    Thebault S; Abdoli M; Fereshtehnejad SM; Tessier D; Tabard-Cossa V; Freedman MS
    Sci Rep; 2020 Jun; 10(1):10381. PubMed ID: 32587320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognostic value of longitudinal measurements of blood neurofilament levels.
    Häring DA; Kropshofer H; Kappos L; Cohen JA; Shah A; Meinert R; Leppert D; Tomic D; Kuhle J
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32817406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of CSF neurofilament light and heavy chain protein in MS.
    Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
    Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
    Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
    Mult Scler; 2018 Jul; 24(8):1046-1054. PubMed ID: 28627962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Neurofilament light correlates with CADASIL disease severity and survival.
    Gravesteijn G; Rutten JW; Verberk IMW; Böhringer S; Liem MK; van der Grond J; Aartsma-Rus A; Teunissen CE; Lesnik Oberstein SAJ
    Ann Clin Transl Neurol; 2019 Jan; 6(1):46-56. PubMed ID: 30656183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
    Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
    Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.
    Sechi E; Mariotto S; McKeon A; Krecke KN; Pittock SJ; Ferrari S; Monaco S; Flanagan EP; Zanzoni S; Rabinstein AA; Wingerchuk DM; Nasr DM; Zalewski NL
    Stroke; 2021 Jan; 52(2):645-654. PubMed ID: 33423516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
    Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum neurofilament light chain as a severity marker for spinocerebellar ataxia.
    Shin HR; Moon J; Lee WJ; Lee HS; Kim EY; Shin S; Lee ST; Jung KH; Park KI; Jung KY; Lee SK; Chu K
    Sci Rep; 2021 Jun; 11(1):13517. PubMed ID: 34188109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
    van Ballegoij WJC; van de Stadt SIW; Huffnagel IC; Kemp S; Willemse EAJ; Teunissen CE; Engelen M
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2127-2136. PubMed ID: 33047897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.